Market Overview

Akerna Announces European Expansion Through MJ Freeway Business

Share:
Akerna Announces European Expansion Through MJ Freeway Business
Read more about our latest Cannabis News! CANNABIS HOME

Akerna Corp (NASDAQ: KERN), a regulatory compliance technology company in the cannabis industry, on Tuesday confirmed an expansion in Europe.

Akerna offers customers a central data management system for tracking regulated cannabis products. The company was born out of the merger of MTech and MJ Freeway.

Akerna said its MJ Freeway business will now serve clients in Italy and Macedonia. MJ Freeway now offers its services to clients in five European countries.

Macedonia is among a small group of countries that approved medical cannabis for cultivation and export. Italy has seen an uptick in hemp production to address its market for industrial products and demand for consumer goods, like cosmetics.

See Also: The Week In Cannabis: Illinois Goes Rec, Federal Commerce And Banking Bills, Surterra's $100M Raise And More

MJ Freeway's new clients include cultivation operators who need enterprise resource planning compliance and inventory management solutions. In conjunction with the European expansion announcement, Akerna said its MJ Freeway business opened operations in Colombia.

It's "imperative" for cannabis companies to have access to Akerna's suite of technology, according to Akerna CEO Jessica Billingsley.

"By giving governments, businesses, and consumers the tools needed to productively manage regulatory demands, we are able to execute our plan to connect data points across the global cannabis supply chain," Billingsley said in the press release.

Akerna shares traded lower by 3.4% to $18.55 at time of publication.

Need more cannabis news? Check out all of our coverage here.

Read more about our latest Cannabis News! CANNABIS HOME

Posted-In: Europe Jessica Billingsley MJ Freeway MTechCannabis News Eurozone Markets Best of Benzinga

 

Related Articles (KERN)

View Comments and Join the Discussion!
Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

Teva's Migraine Prevention Drug Meets Exploratory Endpoints

What Caused The Opening Gap In Aethlon Medical?